glp-1 news past 3 days Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating Medicare GLP-1 access raises questions

Develops Sustainable Habits One of the major pitfalls of using GLP-1 medications is solely relying on them to do the work, which can diminish their effectiveness and may backfire if or when they're discontinued for any reason

The compound's mechanism of action operates through HGF mimetic activity, binding to c-Met receptors expressed on neurons and triggering intracellular signaling cascades that promote synaptogenesis, neurite outgrowth, and dendritic spine formation

[2] Other GLP-1s have similar profiles

Ig-reactive CD4+CD25+ T cells from tolerized (New Zealand Black x New Zealand White) F1 mice suppress in vitro production of antibodies to DNA

Ueda S, Miura K, Kawasaki H, Ogata S, Yamasaki N, Miura S

GHRP-2 produces a strong GH pulse in human volunteers its GH response exceeded that of GHRH and matched hexarelin but is not fully specific, raising prolactin, ACTH, and cortisol, and it significantly increases food intake through its ghrelin-mimetic action